Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Advance Publication


First published on November 3, 2008
A more recent version of this article appeared on January 1, 2009
This version was published on December 9, 2008
Neuro Oncol 2008, DOI:10.1215/15228517-2008-092
This Article
Right arrow Advance Publication Full Text (PDF)
Right arrow All Versions of this Article:
11/3/274    most recent
15228517-2008-092v3
15228517-2008-092v2
15228517-2008-092v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suri, V.
Right arrow Articles by Sarkar, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Copyright 2008 by the Society for Neuro-Oncology

Received March 11, 2008
Accepted October 14, 2008

Basic and Translational Investigations

Pediatric glioblastomas: A histopathological and molecular genetic study

Vaishali Suri 1, Prasenjit Das 1, Ayushi Jain 1, Mehar Chand Sharma 1, Sachin Anil Borkar 1, Ashish Suri 1, Deepak Gupta 1, Chitra Sarkar 2*

1 Departments of Pathology and Neurosurgery, All India Institute of Medical Sciences (AIIMS), New Delhi, India
2 Professor, Department of Pathology, All India Institute of Medical Sciences, Mehrauli Road, Ansari Nagar (W), New Delhi-110029, India

* To whom correspondence should be addressed. E-mail: sarkar.chitra{at}gmail.com.


   Abstract

Glioblastoma multiforme (GBM) occurs rarely in children. Relatively few studies have been performed on molecular properties of pediatric GBMs. To evaluate the genetic alterations in pediatric GBM (age≤18 years) with special reference to p53, p16 and p27 protein expression; epidermal growth factor receptor (EGFR) alterations and phosphate and tensin homolog gene (PTEN) deletion. Thirty cases of childhood GBMs reported between January 2002 to June 2007 were selected and H&E stained slides reviewed. Immunohistochemical staining was performed for EGFR, p53, p16, p27 and MIB 1 labeling index. Fluorescence in situ hybridization (FISH) analysis was performed to evaluate for EGFR amplification and PTEN deletion. Histopathological features and MIB-1 labeling index were similar to adult GBMs. p53 protein expression was observed in 63%. Though EGFR protein over-expression was noted in 23% cases, corresponding amplification of the EGFR gene was rare (5.5%). Deletion of the PTEN gene was also equally rare (5.5%). One case showed polysomy (chromosomal gains) of chromosomes 7 & 10. Loss of p16 and p27 immunoexpression was observed in 68% and 54 % cases respectively. In pediatric de novo/primary GBMs, deletion of PTEN and EGFR amplification are rare, while p53 alterations are more frequent as compared to pimary adult GBMs. Frequency of loss of p16 and p27 immunoexpression is similar to their adult counterparts. This suggests that pediatric malignant gliomas are distinctly different from adult GBMs highlighting the need for identification of molecular targets that may be adopted for future novel therapeutic strategies.

Key Words: epidermal growth factor receptor, glioblastoma multiforme, p16, p27, p53, pediatric, PTEN


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





  Home | Help | Feedback | Subscriptions | Archive | Search | Advance Publication


Copyright 2008 by Society for Neuro-Oncology